Advertisement

Long-term Gonadotropin Administration to Restore Gonadal Function in Male Thalassemics

  • R. Fadini
  • M. R. Rivolta
  • W. Monguzzi
  • E. Lanzi
  • M. Mignini-Renzini
  • A. L. Boneschi

Abstract

A considerable number of patients with β-thalassemia major reach the pubertal age today; regular development of sexual characteristics and a normal reproductive life are important goals for these patients [1]. Absence of pubertal development is seen in 40% of male thalassemics; abnorml sexual maturation is present in 79% [2].

Keywords

Luteinizing Hormone Sexual Maturation Pubertal Development Thalassemic Patient Thalassemia Major 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pearson HA, Guiliotis DK, Rink L, Wells (1987) Patient age distribution in thalassemia major; changes from 1973 to 1985. Pediatrics 80: 53PubMedGoogle Scholar
  2. 2.
    Borgna Pignatti C, De Stefano P, Zonta L,Vullo C, De Sanctis V, Melevendi C, Maselli A, Masera G, Terzoli S, Gabutti U, Piga A (1985) Growth and sexual maturation in thalassemia major. J Pediatr 106: 150CrossRefGoogle Scholar
  3. 3.
    Wilson JD, Griffin JE (1980) The use and misuse of androgens. Metabolism 29: 1278PubMedCrossRefGoogle Scholar
  4. 4.
    Balducci R, Toscaro V, Casilli D, Maroder M, Sciana F, Boscherini B (1987) Testicular responsiveness following chronic administration of hCG in untreated hypogonadotropic hypogonadism. Horm Metab ResGoogle Scholar
  5. 5.
    Tanner JM (1962) Growth at adolescence. Blackwell Scientific, OxfordGoogle Scholar
  6. 6.
    Shephard RJ, Kilinger D, Fried T (1977) Response to sustained use of anabolic steroids. Br J Sports Med 11: 70CrossRefGoogle Scholar
  7. 7.
    Matsumoto AM, Paulsen CA, Bremner WJ (1983) Stimulation of sperm production by human luteinizing hormone in gonadotropin-suppressed normal men. J Clin Endocrinol Metab 59: 882CrossRefGoogle Scholar
  8. 8.
    Matsumoto AM, Karpas AE, Bremner WJ (1986) Human chorionic gonadotropin administration in normal mean: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in men. J Clin Endocrinol Metab 62: 1184PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • R. Fadini
  • M. R. Rivolta
  • W. Monguzzi
  • E. Lanzi
  • M. Mignini-Renzini
  • A. L. Boneschi

There are no affiliations available

Personalised recommendations